Drug /Cue Interactions In Alcohol-Tobacco Comorbidity

NACompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

May 8, 2006

Primary Completion Date

March 31, 2014

Study Completion Date

June 20, 2019

Conditions
Nicotine Dependence
Interventions
BEHAVIORAL

Tobacco

Five research sessions. Session 1: Questionnaires, interviews, computer task, medical evaluation. Sessions 2 - 5: Lab Sessions involving tobacco with brief summary at the end of the last session.

OTHER

Alcoholic Beverage

Five research sessions. Session 1: Questionnaires, interviews, computer task, medical evaluation. Sessions 2 - 5: Lab Sessions involving and alcohol with brief summary at the end of the last session.

OTHER

Placebo

Five research sessions. Session 1: Questionnaires, interviews, computer task, medical evaluation. Sessions 2 - 5: Lab Sessions involving placebo with brief summary at the end of the last session.

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center & Research Institute, Tampa

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT00816231 - Drug /Cue Interactions In Alcohol-Tobacco Comorbidity | Biotech Hunter | Biotech Hunter